Business Description
Guizhou Bailing Group Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000PY3
Share Class Description:
SZSE:002424: Class ACompare
Compare
Traded in other countries / regions
002424.China IPO Date
2010-06-03Description
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company. It is engaged in the production and sale of medicinal tablets, capsules, and syrups.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.09 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.53 | |||||
| Debt-to-EBITDA | -4.39 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.71 | |||||
| Beneish M-Score | -3.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.4 | |||||
| 3-Year FCF Growth Rate | -63.5 | |||||
| 3-Year Book Growth Rate | -3.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.25 | |||||
| 9-Day RSI | 35.45 | |||||
| 14-Day RSI | 39.15 | |||||
| 6-1 Month Momentum % | 28.48 | |||||
| 12-1 Month Momentum % | -50.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.16 | |||||
| Quick Ratio | 0.77 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 246.19 | |||||
| Days Sales Outstanding | 174.6 | |||||
| Days Payable | 163.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -2.36 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.93 | |||||
| Operating Margin % | -6.14 | |||||
| Net Margin % | -11.04 | |||||
| FCF Margin % | 2.49 | |||||
| ROE % | -12.97 | |||||
| ROA % | -6.32 | |||||
| ROIC % | -4.42 | |||||
| ROC (Joel Greenblatt) % | -15.97 | |||||
| ROCE % | -10.76 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.21 | |||||
| PB Ratio | 1.5 | |||||
| Price-to-Tangible-Book | 1.69 | |||||
| Price-to-Free-Cash-Flow | 73.14 | |||||
| Price-to-Operating-Cash-Flow | 43.38 | |||||
| EV-to-EBIT | -16.27 | |||||
| EV-to-EBITDA | -16.27 | |||||
| EV-to-Revenue | 1.61 | |||||
| EV-to-FCF | 65.07 | |||||
| Price-to-Projected-FCF | 1.28 | |||||
| Price-to-Median-PS-Value | 0.28 | |||||
| Price-to-Net-Current-Asset-Value | 20.72 | |||||
| Earnings Yield (Greenblatt) % | -6.15 | |||||
| FCF Yield % | 2.02 | |||||
| Forward Rate of Return (Yacktman) % | -15.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guizhou Bailing Group Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 4,228.644 | ||
| EPS (TTM) (Â¥) | -0.34 | ||
| Beta | 0.74 | ||
| Volatility % | 53.15 | ||
| 14-Day RSI | 39.15 | ||
| 14-Day ATR (Â¥) | 0.112826 | ||
| 20-Day SMA (Â¥) | 3.925 | ||
| 12-1 Month Momentum % | -50.93 | ||
| 52-Week Range (Â¥) | 2.98 - 8.35 | ||
| Shares Outstanding (Mil) | 1,397.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guizhou Bailing Group Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guizhou Bailing Group Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guizhou Bailing Group Pharmaceutical Co Ltd Frequently Asked Questions
What is Guizhou Bailing Group Pharmaceutical Co Ltd(SZSE:002424)'s stock price today?
The current price of SZSE:002424 is ¥3.73. The 52 week high of SZSE:002424 is ¥8.35 and 52 week low is ¥2.98.
When is next earnings date of Guizhou Bailing Group Pharmaceutical Co Ltd(SZSE:002424)?
The next earnings date of Guizhou Bailing Group Pharmaceutical Co Ltd(SZSE:002424) is .
Does Guizhou Bailing Group Pharmaceutical Co Ltd(SZSE:002424) pay dividends? If so, how much?
Guizhou Bailing Group Pharmaceutical Co Ltd(SZSE:002424) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers